Lagarde Michel's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Mar 2, 2022
- Accession no.
- 0001127602-22-007673
- Filed
- Mar 2, 2022
- Trade date
- Mar 1, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $3.30M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lagarde MichelCIK 0001518973 | Officer (Executive Vice President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | SSaleDisposed | −5,100 | $541.25 | −$2,760,375 | 16,878.21 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −1,000 | $541.52 | −$541,520 | 15,878.21 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.